Menopause: Hormone therapy linked to 69% lower risk of thinning bones - Medical News Today
A new study presented at the ENDO 2026 conference suggests that menopausal hormone therapy (MHT) is associated with a 69% lower risk of bone density loss in postmenopausal women. The retrospective study analyzed bone scans from 387 women to evaluate the protective benefits of the treatment.
Why it matters
This research provides further evidence for the clinical benefits of MHT in preventing osteoporosis-related fractures, potentially influencing future treatment guidelines.
Menopausal hormone therapy (MHT) can help to alleviate these symptoms, but it is not suitable for everyone going through the menopause.
The report summarizes medical research findings objectively, citing specific study parameters and limitations.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in